Paragraph 2 Amendment of the Access to Medical Treatments (Innovation) Act 2016I1
United Kingdom
In section 3(2)(b) and (4)(a), (b) and (c) of the Access to Medical Treatments (Innovation) Act 2016 M1 (provision supplementary to section 2: database of innovative treatments) insert “ UK ” before “marketing authorisation”.
Annotations
Marginal citations
- M1
Commencement
- I1
Sch. 8 para. 2 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1